MorphoSys AG (MOR)
17.89
+0.02
(+0.11%)
USD |
NASDAQ |
May 03, 16:00
17.90
+0.01
(+0.06%)
After-Hours: 20:00
MorphoSys Gross Profit Margin (Quarterly): 75.20% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 75.20% |
| September 30, 2023 | 76.33% |
| June 30, 2023 | 85.51% |
| March 31, 2023 | 66.33% |
| December 31, 2022 | 81.00% |
| September 30, 2022 | 91.64% |
| June 30, 2022 | 70.99% |
| March 31, 2022 | 80.97% |
| December 31, 2021 | 82.06% |
| September 30, 2021 | 82.04% |
| June 30, 2021 | 73.49% |
| March 31, 2021 | 89.30% |
| December 31, 2020 | 73.87% |
| September 30, 2020 | 83.07% |
| June 30, 2020 | |
| March 31, 2020 | 98.70% |
| December 31, 2019 | 88.96% |
| September 30, 2019 | 92.21% |
| June 30, 2019 | 85.80% |
| March 31, 2019 | 63.32% |
| December 31, 2018 | 91.49% |
| September 30, 2018 | 98.36% |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | -233.6% |
| September 30, 2011 | 89.98% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
66.33%
Minimum
Mar 2023
98.70%
Maximum
Mar 2020
82.08%
Average
82.05%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Incyte Corp | 93.08% |
| Novartis AG | 74.46% |
| Immatics NV | -- |
| Affimed NV | -- |
| InflaRx NV | -12.02K% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -308.8% |
| Return on Assets | -8.64% |
| Return on Invested Capital | -36.33% |
| Profit Margin (Quarterly) | 81.70% |
| Operating Margin (Quarterly) | -137.7% |
| Return on Net Operating Assets | -12.30% |